NBTM(600114) 证券时报网·2025-03-10 11:14Group 1 - The company Dongmu Co., Ltd. plans to acquire a 20.75% stake in Shanghai Fuchi through a combination of share issuance and cash payment to four parties [1] - The company primarily engages in the research, production, sales, and value-added services of new materials and products, with revenue mainly derived from two business segments: P&S and SMC [1] - After acquiring control of Shanghai Fuchi in 2020, the company quickly entered the MIM (Metal Injection Molding) field, expanding its business into communication terminal and medical device industries [1][2] Group 2 - MIM technology combines the advantages of powder metallurgy and plastic injection molding, making it suitable for producing complex and high-performance components [2] - The global market for MIM products is experiencing rapid growth, driven by increasing demand for material diversification and lightweight products in various sectors, including communications, automotive, and medical devices [2] - Shanghai Fuchi's products are widely used across multiple industries, making it a core strategic resource for enhancing industrial competitiveness and advancing to higher levels of the global value chain [2] Group 3 - Shanghai Fuchi reported revenues of 1.173 billion, 1.036 billion, and 1.283 billion yuan for the years 2022, 2023, and the first nine months of 2024, respectively, with net profits of 3.0142 million, -55.6163 million, and 65.1493 million yuan [3] - Prior to the transaction, Dongmu Co., Ltd. held a 64.25% stake in Shanghai Fuchi, which will increase post-transaction, enhancing control and resource integration [3] - The transaction is expected to strengthen the company's control over Shanghai Fuchi, enhance business synergy, and accelerate the construction of an innovation ecosystem, thereby consolidating its competitive advantage in high-end manufacturing [3]